Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria

Mark Charbonneau et al. develop a mathematical model that describes the behavior of an engineered bacterial therapeutic, SYNB1618, in the human gastrointestinal tract and its effects on plasma phenylalanine (Phe) levels. This model enables the authors to predict plasma Phe lowering by SYNB1618 in pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mark R. Charbonneau, William S. Denney, Nicholas G. Horvath, Pasquale Cantarella, Mary J. Castillo, Marja K. Puurunen, Aoife M. Brennan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/9c842b6d19dd4ea5ab162237138ababd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9c842b6d19dd4ea5ab162237138ababd
record_format dspace
spelling oai:doaj.org-article:9c842b6d19dd4ea5ab162237138ababd2021-12-02T16:17:32ZDevelopment of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria10.1038/s42003-021-02183-12399-3642https://doaj.org/article/9c842b6d19dd4ea5ab162237138ababd2021-07-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02183-1https://doaj.org/toc/2399-3642Mark Charbonneau et al. develop a mathematical model that describes the behavior of an engineered bacterial therapeutic, SYNB1618, in the human gastrointestinal tract and its effects on plasma phenylalanine (Phe) levels. This model enables the authors to predict plasma Phe lowering by SYNB1618 in patients with phenylketonuria.Mark R. CharbonneauWilliam S. DenneyNicholas G. HorvathPasquale CantarellaMary J. CastilloMarja K. PuurunenAoife M. BrennanNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Mark R. Charbonneau
William S. Denney
Nicholas G. Horvath
Pasquale Cantarella
Mary J. Castillo
Marja K. Puurunen
Aoife M. Brennan
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
description Mark Charbonneau et al. develop a mathematical model that describes the behavior of an engineered bacterial therapeutic, SYNB1618, in the human gastrointestinal tract and its effects on plasma phenylalanine (Phe) levels. This model enables the authors to predict plasma Phe lowering by SYNB1618 in patients with phenylketonuria.
format article
author Mark R. Charbonneau
William S. Denney
Nicholas G. Horvath
Pasquale Cantarella
Mary J. Castillo
Marja K. Puurunen
Aoife M. Brennan
author_facet Mark R. Charbonneau
William S. Denney
Nicholas G. Horvath
Pasquale Cantarella
Mary J. Castillo
Marja K. Puurunen
Aoife M. Brennan
author_sort Mark R. Charbonneau
title Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
title_short Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
title_full Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
title_fullStr Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
title_full_unstemmed Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
title_sort development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9c842b6d19dd4ea5ab162237138ababd
work_keys_str_mv AT markrcharbonneau developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
AT williamsdenney developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
AT nicholasghorvath developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
AT pasqualecantarella developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
AT maryjcastillo developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
AT marjakpuurunen developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
AT aoifembrennan developmentofamechanisticmodeltopredictsyntheticbioticactivityinhealthyvolunteersandpatientswithphenylketonuria
_version_ 1718384246497738752